Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Shanton Pharma’s SAP-001 earns FDA Fast Track status for refractory gout treatment FDA grants Fast Track designation to Shanton Pharma’s SAP-001 for refractory gout; company plans accelerated development and Phase 3 trials. bySoujanya RaviJuly 25, 2025